Ratings by BofA Securities (Jason Gerberry)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 2/26/2026 | Viatris | VTRS | Maintain | Underperform (N/A) |
|
Details | ||
| 2/24/2026 | Harmony Biosciences Holdings Inc. | HRMY | Maintain | Underperform (N/A) |
|
Details | ||
| 2/20/2026 | Alkermes | ALKS | Maintain | Neutral (N/A) |
|
Details | ||
| 2/4/2026 | LENZ Therapeutics Inc | LENZ | Maintain | Buy (N/A) |
|
Details | ||
| 1/28/2026 | Teva Pharma | TEVA | Maintain | Buy (N/A) |
|
Details | ||
| 1/9/2026 | Jazz Pharmaceuticals | JAZZ | Maintain | Buy (N/A) |
|
Details | ||
| 1/7/2026 | Arrowhead Pharma | ARWR | Maintain | Buy (N/A) |
|
Details | ||
| 1/7/2026 | Jazz Pharmaceuticals | JAZZ | Maintain | Buy (N/A) |
|
Details | ||
| 1/5/2026 | Exelixis | EXEL | Downgrade | Underperform (Neutral) |
43.58 (41.55) |
-4.66% | Details | |
| 12/1/2025 | Arrowhead Pharma | ARWR | Maintain | Buy (N/A) |
|
Details | ||
| 11/18/2025 | Jazz Pharmaceuticals | JAZZ | Maintain | Buy (N/A) |
|
Details | ||
| 11/12/2025 | Alkermes | ALKS | Maintain | Neutral (N/A) |
|
Details | ||
| 11/5/2025 | Biohaven Pharmaceutical Holding | BHVN | Downgrade | Neutral (Buy) |
13.95 (9.92) |
-28.89% | Details | |
| 10/28/2025 | Alkermes | ALKS | Maintain | Neutral (N/A) |
|
Details | ||
| 10/6/2025 | Oculis Holding AG | OCS | Maintain | Buy (N/A) |
|
Details | ||
| 9/22/2025 | Ionis Pharmaceuticals | IONS | Maintain | Buy (N/A) |
|
Details | ||
| 8/25/2025 | Amphastar Pharmaceuticals | AMPH | Maintain | Neutral (N/A) |
|
Details | ||
| 8/21/2025 | Ionis Pharmaceuticals | IONS | Maintain | Buy (N/A) |
|
Details | ||
| 8/14/2025 | Jazz Pharmaceuticals | JAZZ | Maintain | Buy (N/A) |
|
Details | ||
| 7/29/2025 | Alkermes | ALKS | Maintain | Neutral (N/A) |
|
Details | ||
| 7/21/2025 | Alkermes | ALKS | Maintain | Neutral (N/A) |
|
Details | ||
| 7/15/2025 | Teva Pharma | TEVA | Maintain | Buy (N/A) |
|
Details | ||
| 7/9/2025 | ProKidney Corp. | PROK | Maintain | Underperform (N/A) |
|
Details | ||
| 7/8/2025 | ProKidney Corp. | PROK | Maintain | Underperform (N/A) |
|
Details | ||
| 6/30/2025 | ProKidney Corp. | PROK | Downgrade | Underperform (Neutral) |
3.00 (2.30) |
-23.33% | Details | |
| 6/5/2025 | Exelixis | EXEL | Maintain | Neutral (N/A) |
|
Details | ||
| 5/6/2025 | Axsome Therapeutics | AXSM | Maintain | Buy (N/A) |
|
Details | ||
| 4/11/2025 | Jazz Pharmaceuticals | JAZZ | Maintain | Buy (N/A) |
|
Details | ||
| 4/1/2025 | Axsome Therapeutics | AXSM | Maintain | Buy (N/A) |
|
Details | ||
| 3/19/2025 | Immunovant | IMVT | Maintain | Buy (N/A) |
|
Details | ||
| 3/6/2025 | Teva Pharma | TEVA | Maintain | Buy (N/A) |
|
Details | ||
| 2/27/2025 | Viatris | VTRS | Maintain | Underperform (N/A) |
|
Details | ||
| 2/11/2025 | Arrowhead Pharma | ARWR | Maintain | Buy (N/A) |
|
Details | ||
| 2/10/2025 | Axsome Therapeutics | AXSM | Maintain | Buy (N/A) |
|
Details | ||
| 1/29/2025 | Teva Pharma | TEVA | Maintain | Buy (N/A) |
|
Details | ||
| 1/10/2025 | Intra-Cellular Therapies | ITCI | Maintain | Buy (N/A) |
|
Details | ||
| 12/17/2024 | Exelixis | EXEL | Downgrade | Neutral (Buy) |
36.07 (41.55) |
15.19% | Details | |
| 12/12/2024 | Relay Therapeutics | RLAY | Maintain | Buy (N/A) |
|
Details | ||
| 12/9/2024 | Arcellx Inc. | ACLX | Maintain | Buy (N/A) |
|
Details | ||
| 12/3/2024 | Teva Pharma | TEVA | Maintain | Buy (N/A) |
|
Details | ||
| 11/15/2024 | bluebird bio | BLUE | Downgrade | Neutral (Buy) |
0.36 (4.97) |
1280.56% | Details | |
| 11/5/2024 | Arcellx Inc. | ACLX | Maintain | Buy (N/A) |
|
Details | ||
| 10/16/2024 | Exelixis | EXEL | Maintain | Buy (N/A) |
|
Details | ||
| 10/15/2024 | Biohaven Pharmaceutical Holding | BHVN | Maintain | Buy (N/A) |
|
Details | ||
| 10/7/2024 | Biohaven Pharmaceutical Holding | BHVN | Maintain | Buy (N/A) |
|
Details | ||
| 10/1/2024 | Teva Pharma | TEVA | Maintain | Buy (N/A) |
|
Details | ||
| 9/24/2024 | Biohaven Pharmaceutical Holding | BHVN | Maintain | Buy (N/A) |
|
Details | ||
| 9/9/2024 | Immunovant | IMVT | Maintain | Buy (N/A) |
|
Details | ||
| 9/4/2024 | Relay Therapeutics | RLAY | Maintain | Buy (N/A) |
|
Details | ||
| 9/4/2024 | Exelixis | EXEL | Maintain | Buy (N/A) |
|
Details | ||
| 9/4/2024 | Vaxcyte | PCVX | Maintain | Buy (N/A) |
|
Details | ||
| 9/4/2024 | ProKidney Corp. | PROK | Maintain | Neutral (N/A) |
|
Details | ||
| 8/9/2024 | Viatris | VTRS | Maintain | Underperform (N/A) |
|
Details | ||
| 8/6/2024 | Axsome Therapeutics | AXSM | Upgrade | Buy (Neutral) |
83.21 (162.33) |
95.08% | Details | |
| 6/21/2024 | Vaxcyte | PCVX | Maintain | Buy (N/A) |
|
Details | ||
| 6/11/2024 | ProKidney Corp. | PROK | Maintain | Neutral (N/A) |
|
Details | ||
| 6/11/2024 | Oculis Holding AG | OCS | Maintain | Buy (N/A) |
|
Details | ||
| 5/29/2024 | ProKidney Corp. | PROK | Maintain | Neutral (N/A) |
|
Details | ||
| 5/14/2024 | Fractyl Health Inc | GUTS | Maintain | Buy (N/A) |
|
Details | ||
| 5/10/2024 | Tarsus Pharmaceuticals | TARS | Maintain | Buy (N/A) |
|
Details | ||
| 5/7/2024 | Lyra Therapeutics | LYRA | Downgrade | Underperform (Buy) |
0.52 (1.28) |
146.15% | Details | |
| 5/2/2024 | Alkermes | ALKS | Maintain | Neutral (N/A) |
|
Details | ||
| 5/2/2024 | Lyra Therapeutics | LYRA | Maintain | Buy (N/A) |
|
Details | ||
| 4/17/2024 | Intra-Cellular Therapies | ITCI | Maintain | Buy (N/A) |
|
Details | ||
| 3/28/2024 | Galapagos NV | GLPG | Downgrade | Underperform (Neutral) |
32.95 (32.92) |
-0.09% | Details | |
| 2/28/2024 | Tarsus Pharmaceuticals | TARS | Maintain | Buy (N/A) |
|
Details | ||
| 2/28/2024 | Amphastar Pharmaceuticals | AMPH | Maintain | Buy (N/A) |
|
Details | ||
| 2/27/2024 | Fractyl Health Inc | GUTS | New Coverage | Buy (N/A) |
7.60 (0.48) |
-93.68% | Details | |
| 2/8/2024 | bluebird bio | BLUE | Maintain | Buy (N/A) |
|
Details | ||
| 2/6/2024 | Vaxcyte | PCVX | Maintain | Buy (N/A) |
|
Details | ||
| 1/12/2024 | Axsome Therapeutics | AXSM | Maintain | Neutral (N/A) |
|
Details | ||
| 1/12/2024 | Teva Pharma | TEVA | Maintain | Buy (N/A) |
|
Details | ||
| 1/10/2024 | Arrowhead Pharma | ARWR | Maintain | Buy (N/A) |
|
Details | ||
| 1/2/2024 | ProKidney Corp. | PROK | Downgrade | Neutral (Buy) |
1.78 (3.00) |
68.54% | Details | |
| 1/2/2024 | Ionis Pharmaceuticals | IONS | Upgrade | Buy (Neutral) |
50.59 (74.04) |
46.35% | Details | |
| 1/2/2024 | Harmony Biosciences Holdings Inc. | HRMY | Downgrade | Underperform (Neutral) |
32.30 (28.33) |
-12.29% | Details | |
| 12/11/2023 | bluebird bio | BLUE | Maintain | Buy (N/A) |
|
Details | ||
| 12/4/2023 | Arrowhead Pharma | ARWR | New Coverage | Buy (N/A) |
23.17 (59.82) |
158.18% | Details | |
| 11/17/2023 | Amphastar Pharmaceuticals | AMPH | New Coverage | Neutral (N/A) |
56.17 (19.34) |
-65.57% | Details | |
| 11/15/2023 | ProKidney Corp. | PROK | Maintain | Buy (N/A) |
|
Details | ||
| 11/6/2023 | Galapagos NV | GLPG | Maintain | Neutral (N/A) |
|
Details | ||
| 11/3/2023 | Karuna Therapeutics Inc. | KRTX | Maintain | Buy (N/A) |
|
Details | ||
| 11/3/2023 | Intra-Cellular Therapies | ITCI | Maintain | Buy (N/A) |
|
Details | ||
| 10/23/2023 | Ionis Pharmaceuticals | IONS | Upgrade | Neutral (Underperform) |
46.16 (74.04) |
60.4% | Details | |
| 10/23/2023 | Viatris | VTRS | Downgrade | Underperform (Neutral) |
9.30 (14.16) |
52.26% | Details | |
| 10/16/2023 | Harmony Biosciences Holdings Inc. | HRMY | Maintain | Neutral (N/A) |
|
Details | ||
| 9/13/2023 | Lyra Therapeutics | LYRA | Maintain | Buy (N/A) |
|
Details | ||
| 9/8/2023 | Teva Pharma | TEVA | Maintain | Buy (N/A) |
|
Details | ||
| 9/8/2023 | Karuna Therapeutics Inc. | KRTX | Maintain | Buy (N/A) |
|
Details | ||
| 9/5/2023 | Axsome Therapeutics | AXSM | Maintain | Neutral (N/A) |
|
Details | ||
| 8/29/2023 | Oculis Holding AG | OCS | Maintain | Buy (N/A) |
|
Details | ||
| 8/9/2023 | Oculis Holding AG | OCS | Maintain | Buy (N/A) |
|
Details | ||
| 8/9/2023 | Cara Therapeutics | CARA | Maintain | Underperform (N/A) |
|
Details | ||
| 8/9/2023 | bluebird bio | BLUE | Maintain | Buy (N/A) |
|
Details | ||
| 8/9/2023 | Lyra Therapeutics | LYRA | Maintain | Buy (N/A) |
|
Details | ||
| 8/9/2023 | Vaxcyte | PCVX | Maintain | Buy (N/A) |
|
Details | ||
| 8/9/2023 | Mirati Therapeutics | MRTX | Maintain | Neutral (N/A) |
|
Details | ||
| 8/8/2023 | FibroGen | FGEN | Downgrade | Underperform (Neutral) |
1.77 (9.71) |
448.59% | Details | |
| 8/8/2023 | Axsome Therapeutics | AXSM | Upgrade | Buy (Underperform) |
71.09 (162.33) |
128.34% | Details | |
| 8/3/2023 | Coherus Biosciences | CHRS | Maintain | Neutral (N/A) |
|
Details | ||
| 8/3/2023 | Teva Pharma | TEVA | Maintain | Buy (N/A) |
|
Details | ||
| 7/19/2023 | bluebird bio | BLUE | Upgrade | Buy (Neutral) |
3.15 (0.36) |
-88.57% | Details | |
| 6/26/2023 | FibroGen | FGEN | Downgrade | Neutral (Buy) |
16.05 (9.71) |
-39.5% | Details | |
| 6/14/2023 | Oculis Holding AG | OCS | New Coverage | Buy (N/A) |
11.50 (26.96) |
134.43% | Details | |
| 5/16/2023 | Cara Therapeutics | CARA | Maintain | Underperform (N/A) |
|
Details | ||
| 5/10/2023 | Xenon Pharmaceuticals | XENE | Maintain | Buy (N/A) |
|
Details | ||
| 5/5/2023 | Bausch Health Companies | BHC | Maintain | Underperform (N/A) |
|
Details | ||
| 5/5/2023 | Relay Therapeutics | RLAY | Maintain | Buy (N/A) |
|
Details | ||
| 5/5/2023 | Intra-Cellular Therapies | ITCI | Maintain | Buy (N/A) |
|
Details | ||
| 5/5/2023 | Karuna Therapeutics Inc. | KRTX | Maintain | Buy (N/A) |
|
Details | ||
| 5/5/2023 | Organon & Co. | OGN | Maintain | Underperform (N/A) |
|
Details | ||
| 5/1/2023 | Immunovant | IMVT | New Coverage | Buy (N/A) |
16.14 (26.66) |
65.18% | Details | |
| 4/20/2023 | Harmony Biosciences Holdings Inc. | HRMY | New Coverage | Neutral (N/A) |
32.97 (28.33) |
-14.07% | Details | |
| 4/18/2023 | Vaxcyte | PCVX | Maintain | Buy (N/A) |
|
Details | ||
| 3/8/2023 | Cara Therapeutics | CARA | Downgrade | Underperform (Neutral) |
10.02 (5.32) |
-46.91% | Details | |
| 3/7/2023 | Coherus Biosciences | CHRS | Maintain | Neutral (N/A) |
|
Details | ||
| 2/28/2023 | Vaxcyte | PCVX | Maintain | Buy (N/A) |
|
Details | ||
| 2/28/2023 | FibroGen | FGEN | Maintain | Buy (N/A) |
|
Details | ||
| 1/9/2023 | Exelixis | EXEL | Maintain | Buy (N/A) |
|
Details | ||
| 1/5/2023 | Organon & Co. | OGN | Maintain | Underperform (N/A) |
|
Details | ||
| 1/5/2023 | Federated National Holding | FNHC | Maintain | Buy (N/A) |
|
Details | ||
| 1/5/2023 | BeyondSpring Inc. | BYSI | Maintain | Underperform (N/A) |
|
Details | ||
| 1/5/2023 | FibroGen | FGEN | Upgrade | Buy (Neutral) |
16.10 (9.71) |
-39.69% | Details | |
| 1/3/2023 | Alkermes | ALKS | Maintain | Neutral (N/A) |
|
Details | ||
| 12/13/2022 | Arcellx Inc. | ACLX | New Coverage | Buy (N/A) |
28.52 (114.33) |
300.88% | Details | |
| 12/13/2022 | Mirati Therapeutics | MRTX | Maintain | Neutral (N/A) |
|
Details | ||
| 12/9/2022 | Mirati Therapeutics | MRTX | Maintain | Neutral (N/A) |
|
Details | ||
| 12/9/2022 | Exelixis | EXEL | Maintain | Buy (N/A) |
|
Details | ||
| 12/8/2022 | Mirati Therapeutics | MRTX | Maintain | Neutral (N/A) |
|
Details | ||
| 11/28/2022 | Mirati Therapeutics | MRTX | Maintain | Neutral (N/A) |
|
Details | ||
| 11/15/2022 | Arcellx Inc. | ACLX | Maintain | Buy (N/A) |
|
Details | ||
| 11/8/2022 | Viatris | VTRS | Maintain | Neutral (N/A) |
|
Details | ||
| 10/14/2022 | Jazz Pharmaceuticals | JAZZ | Maintain | Buy (N/A) |
|
Details | ||
| 10/14/2022 | Teva Pharma | TEVA | Maintain | Buy (N/A) |
|
Details | ||
| 10/14/2022 | Viatris | VTRS | Maintain | Neutral (N/A) |
|
Details | ||
| 10/14/2022 | Horizon Therapeutics | HZNP | Maintain | Buy (N/A) |
|
Details | ||
| 10/14/2022 | Axsome Therapeutics | AXSM | Maintain | Underperform (N/A) |
|
Details | ||
| 10/14/2022 | Intra-Cellular Therapies | ITCI | Maintain | Buy (N/A) |
|
Details | ||
| 10/14/2022 | Mirati Therapeutics | MRTX | Maintain | Neutral (N/A) |
|
Details | ||
| 10/14/2022 | Alkermes | ALKS | Upgrade | Neutral (Underperform) |
22.72 (28.63) |
26.01% | Details | |
| 10/14/2022 | Organon & Co. | OGN | Downgrade | Underperform (Neutral) |
24.03 (6.56) |
-72.7% | Details | |
| 10/12/2022 | DICE Therapeutics | DICE | Maintain | Buy (N/A) |
|
Details | ||
| 9/29/2022 | Jazz Pharmaceuticals | JAZZ | Maintain | Buy (N/A) |
|
Details | ||
| 9/23/2022 | ProKidney Corp. | PROK | New Coverage | Buy (N/A) |
8.87 (2.30) |
-74.07% | Details | |
| 9/20/2022 | bluebird bio | BLUE | Maintain | Neutral (N/A) |
|
Details | ||
| 9/13/2022 | Mirati Therapeutics | MRTX | Maintain | Buy (N/A) |
|
Details | ||
| 8/29/2022 | Xenon Pharmaceuticals | XENE | New Coverage | Buy (N/A) |
36.97 (41.94) |
13.44% | Details | |
| 8/18/2022 | Karuna Therapeutics Inc. | KRTX | Maintain | Buy (N/A) |
|
Details | ||
| 8/18/2022 | Relay Therapeutics | RLAY | New Coverage | Buy (N/A) |
19.34 (9.89) |
-48.86% | Details | |
| 8/8/2022 | Mirati Therapeutics | MRTX | Maintain | Neutral (N/A) |
|
Details | ||
| 8/5/2022 | Teva Pharma | TEVA | Upgrade | Buy (Neutral) |
10.12 (31.05) |
206.82% | Details | |
| 8/5/2022 | Organon & Co. | OGN | Downgrade | Neutral (Buy) |
32.41 (24.03) |
-25.86% | Details | |
| 7/11/2022 | Teva Pharma | TEVA | Maintain | Neutral (N/A) |
|
Details | ||
| 7/11/2022 | Intra-Cellular Therapies | ITCI | Maintain | Buy (N/A) |
|
Details | ||
| 7/11/2022 | Ionis Pharmaceuticals | IONS | Maintain | Underperform (N/A) |
|
Details | ||
| 7/11/2022 | Horizon Therapeutics | HZNP | Maintain | Buy (N/A) |
|
Details | ||
| 7/11/2022 | Coherus Biosciences | CHRS | Maintain | Neutral (N/A) |
|
Details | ||
| 7/11/2022 | Bausch Health Companies | BHC | Maintain | Underperform (N/A) |
|
Details | ||
| 6/29/2022 | Axsome Therapeutics | AXSM | Maintain | Underperform (N/A) |
|
Details | ||
| 6/29/2022 | Mirati Therapeutics | MRTX | Maintain | Neutral (N/A) |
|
Details | ||
| 6/7/2022 | Mirati Therapeutics | MRTX | Maintain | Neutral (N/A) |
|
Details | ||
| 6/2/2022 | Axsome Therapeutics | AXSM | Maintain | Buy (N/A) |
|
Details | ||
| 6/1/2022 | Vaxcyte | PCVX | Maintain | Buy (N/A) |
|
Details | ||
| 5/17/2022 | Finch Therapeutics Group Inc. | FNCH | Maintain | Buy (N/A) |
|
Details | ||
| 5/17/2022 | Teva Pharma | TEVA | Upgrade | Neutral (Underperform) |
7.91 (31.05) |
292.54% | Details | |
| 3/28/2022 | Karuna Therapeutics Inc. | KRTX | Maintain | Buy (N/A) |
|
Details | ||
| 3/8/2022 | bluebird bio | BLUE | Maintain | Buy (N/A) |
|
Details | ||
| 3/1/2022 | Arcellx Inc. | ACLX | New Coverage | Buy (N/A) |
19.14 (114.33) |
497.34% | Details | |
| 3/1/2022 | Viatris | VTRS | Downgrade | Neutral (Buy) |
11.01 (14.16) |
28.61% | Details | |
| 2/1/2022 | Ionis Pharmaceuticals | IONS | Downgrade | Underperform (Buy) |
31.80 (74.04) |
132.83% | Details | |
| 2/1/2022 | Mirati Therapeutics | MRTX | Upgrade | Neutral (Underperform) |
119.30 (58.70) |
-50.8% | Details | |
| 12/8/2021 | Ionis Pharmaceuticals | IONS | Maintain | Buy (N/A) |
|
Details | ||
| 12/2/2021 | BeyondSpring Inc. | BYSI | Downgrade | Underperform (Buy) |
12.77 (1.45) |
-88.65% | Details | |
| 11/16/2021 | Alkermes | ALKS | Maintain | Underperform (N/A) |
|
Details | ||
| 11/16/2021 | bluebird bio | BLUE | Maintain | Neutral (N/A) |
|
Details | ||
| 11/12/2021 | Organon & Co. | OGN | Maintain | Buy (N/A) |
|
Details | ||
| 11/11/2021 | FibroGen | FGEN | Maintain | Neutral (N/A) |
|
Details | ||
| 11/10/2021 | Jazz Pharmaceuticals | JAZZ | Maintain | Buy (N/A) |
|
Details | ||
| 11/9/2021 | Cara Therapeutics | CARA | Maintain | Neutral (N/A) |
|
Details | ||
| 11/9/2021 | Viatris | VTRS | Maintain | Buy (N/A) |
|
Details | ||
| 11/9/2021 | Alkermes | ALKS | Maintain | Underperform (N/A) |
|
Details | ||
| 11/8/2021 | Galapagos NV | GLPG | Maintain | Neutral (N/A) |
|
Details | ||
| 10/26/2021 | Horizon Therapeutics | HZNP | Maintain | Buy (N/A) |
|
Details | ||
| 10/18/2021 | Ionis Pharmaceuticals | IONS | Maintain | Buy (N/A) |
|
Details | ||
| 10/11/2021 | DICE Therapeutics | DICE | New Coverage | Buy (N/A) |
26.49 (47.55) |
79.5% | Details | |
| 9/17/2021 | Horizon Therapeutics | HZNP | Maintain | Buy (N/A) |
|
Details | ||
| 9/13/2021 | BeyondSpring Inc. | BYSI | Maintain | Buy (N/A) |
|
Details | ||
| 9/2/2021 | Alkermes | ALKS | Downgrade | Underperform (Neutral) |
31.25 (22.72) |
-27.3% | Details | |
| 9/1/2021 | Organon & Co. | OGN | New Coverage | Buy (N/A) |
33.89 (6.56) |
-80.64% | Details | |
| 8/4/2021 | Bausch Health Companies | BHC | Maintain | Underperform (N/A) |
|
Details | ||
| 8/4/2021 | Jazz Pharmaceuticals | JAZZ | Maintain | Buy (N/A) |
|
Details | ||
| 7/16/2021 | FibroGen | FGEN | Downgrade | Neutral (Buy) |
24.84 (9.71) |
-60.91% | Details | |
| 6/28/2021 | FibroGen | FGEN | Maintain | Buy (N/A) |
|
Details | ||
| 6/22/2021 | Jazz Pharmaceuticals | JAZZ | Maintain | Buy (N/A) |
|
Details | ||
| 6/22/2021 | Tarsus Pharmaceuticals | TARS | Maintain | Buy (N/A) |
|
Details | ||
| 5/25/2021 | Eli Lilly | LLY | Maintain | Buy (N/A) |
|
Details | ||
| 3/30/2021 | Vaxcyte | PCVX | Maintain | Buy (N/A) |
|
Details | ||
| 3/11/2021 | bluebird bio | BLUE | Maintain | Neutral (N/A) |
|
Details | ||
| 3/4/2021 | Coherus Biosciences | CHRS | Maintain | Neutral (N/A) |
|
Details | ||
| 2/24/2021 | Jazz Pharmaceuticals | JAZZ | Maintain | Buy (N/A) |
|
Details | ||
| 2/9/2021 | Horizon Therapeutics | HZNP | Maintain | Buy (N/A) |
|
Details | ||
| 1/11/2021 | BeyondSpring Inc. | BYSI | New Coverage | Buy (N/A) |
12.62 (1.45) |
-88.51% | Details | |
| 12/11/2020 | Alkermes | ALKS | Maintain | Neutral (N/A) |
|
Details | ||
| 12/1/2020 | Horizon Therapeutics | HZNP | Maintain | Buy (N/A) |
|
Details | ||
| 11/3/2020 | Horizon Therapeutics | HZNP | Maintain | Buy (N/A) |
|
Details | ||
| 10/26/2020 | Mirati Therapeutics | MRTX | Maintain | Neutral (N/A) |
|
Details | ||
| 10/21/2020 | Cara Therapeutics | CARA | Maintain | Neutral (N/A) |
|
Details | ||
| 10/12/2020 | Arena Pharma | ARNA | Maintain | Buy (N/A) |
|
Details | ||
| 8/21/2020 | Galapagos NV | GLPG | Maintain | Underperform (N/A) |
|
Details | ||
| 8/6/2020 | Horizon Therapeutics | HZNP | Maintain | Buy (N/A) |
|
Details | ||
| 7/22/2020 | Arena Pharma | ARNA | Maintain | Buy (N/A) |
|
Details | ||
| 7/7/2020 | Vaxcyte | PCVX | New Coverage | Buy (N/A) |
29.38 (59.29) |
101.8% | Details | |
| 6/19/2020 | Eli Lilly | LLY | Maintain | Buy (Buy) |
|
Details | ||
| 5/26/2020 | Horizon Therapeutics | HZNP | Maintain | Buy (N/A) |
|
Details | ||
| 4/22/2020 | Eli Lilly | LLY | Maintain | Buy (N/A) |
|
Details | ||
| 4/22/2020 | Cara Therapeutics | CARA | Maintain | Neutral (N/A) |
|
Details | ||
| 3/26/2020 | Galapagos NV | GLPG | Maintain | Underperform (N/A) |
|
Details | ||
| 2/25/2020 | Horizon Therapeutics | HZNP | Maintain | Buy (N/A) |
|
Details | ||
| 2/14/2020 | Alkermes | ALKS | Downgrade | Neutral (Buy) |
17.65 (28.63) |
62.21% | Details | |
| 2/13/2020 | Teva Pharma | TEVA | Maintain | Underperform (N/A) |
|
Details | ||
| 1/31/2020 | Jazz Pharmaceuticals | JAZZ | Maintain | Buy (N/A) |
|
Details | ||
| 1/13/2020 | Exelixis | EXEL | Maintain | Buy (N/A) |
|
Details | ||
| 1/13/2020 | Exelixis | EXEL | Maintain | Buy (N/A) |
|
Details | ||
| 12/31/2019 | Ionis Pharmaceuticals | IONS | Maintain | Buy (N/A) |
|
Details | ||
| 11/13/2019 | Exelixis | EXEL | New Coverage | Buy (N/A) |
15.34 (41.55) |
170.86% | Details | |
| 11/13/2019 | Arena Pharma | ARNA | New Coverage | Neutral (N/A) |
46.17 (41.50) |
-10.11% | Details | |
| 10/17/2019 | Eli Lilly | LLY | New Coverage | Buy (N/A) |
109.70 (990.33) |
802.76% | Details | |
| 10/10/2019 | Bristol-Myers Squibb Co. | BMY | Maintain | Neutral (N/A) |
|
Details | ||
| 9/12/2019 | Jazz Pharmaceuticals | JAZZ | Maintain | Buy (N/A) |
|
Details | ||
| 9/10/2019 | Eli Lilly | LLY | Maintain | Neutral (N/A) |
|
Details | ||
| 9/5/2019 | Mallinckrodt plc | MNK | Maintain | Underperform (N/A) |
|
Details | ||
| 9/3/2019 | Bristol-Myers Squibb Co. | BMY | Maintain | Neutral (N/A) |
|
Details | ||
| 8/20/2019 | Nabriva Therapeutics AG | NBRV | Maintain | Buy (N/A) |
|
Details | ||
| 7/30/2019 | Pfizer | PFE | Downgrade | Neutral (Buy) |
41.45 (36.50) |
-11.94% | Details | |
| 6/25/2019 | Abbvie | ABBV | Maintain | Neutral (N/A) |
|
Details | ||
| 6/21/2019 | Merck | MRK | Maintain | Buy (N/A) |
|
Details | ||
| 5/30/2019 | Teva Pharma | TEVA | Downgrade | Underperform (Neutral) |
9.70 (31.05) |
220.1% | Details | |
| 5/1/2019 | Merck | MRK | Maintain | Buy (N/A) |
|
Details | ||
| 4/1/2019 | Pfizer | PFE | Maintain | Buy (N/A) |
|
Details | ||
| 3/27/2019 | Jazz Pharmaceuticals | JAZZ | Maintain | Buy (N/A) |
|
Details | ||
| 3/20/2019 | Banco de Chile | BCH | New Coverage | Underperform (N/A) |
31.19 (38.03) |
21.93% | Details | |
| 3/7/2019 | Allergen | AGN | Maintain | Buy (N/A) |
|
Details | ||
| 2/19/2019 | Bristol-Myers Squibb Co. | BMY | Maintain | Neutral (N/A) |
|
Details | ||
| 1/30/2019 | Allergen | AGN | Maintain | Buy (N/A) |
|
Details | ||
| 1/30/2019 | Pfizer | PFE | Maintain | Buy (N/A) |
|
Details | ||
| 1/28/2019 | Abbvie | ABBV | Maintain | Neutral (N/A) |
|
Details | ||
| 1/25/2019 | Bristol-Myers Squibb Co. | BMY | Maintain | Neutral (N/A) |
|
Details | ||
| 1/15/2019 | Cara Therapeutics | CARA | New Coverage | Neutral (N/A) |
15.83 (5.32) |
-66.39% | Details | |
| 1/3/2019 | Mylan | MYL | Maintain | Buy (N/A) |
|
Details | ||
| 1/3/2019 | Allergen | AGN | Maintain | Buy (N/A) |
|
Details | ||
| 1/3/2019 | Eli Lilly | LLY | Maintain | Neutral (N/A) |
|
Details | ||
| 1/3/2019 | Merck | MRK | Maintain | Buy (N/A) |
|
Details | ||
| 1/3/2019 | Abbvie | ABBV | Downgrade | Neutral (Buy) |
89.23 (230.11) |
157.88% | Details | |
| 1/3/2019 | Teva Pharma | TEVA | Upgrade | Buy (Underperform) |
15.85 (9.70) |
-38.8% | Details | |
| 12/12/2018 | Foamix Pharmaceuticals | FOMX | New Coverage | Buy (N/A) |
4.00 (2.99) |
-25.25% | Details | |
| 11/30/2018 | Alkermes | ALKS | Maintain | Buy (N/A) |
|
Details | ||
| 11/6/2018 | Mylan | MYL | Upgrade | Buy (Neutral) |
31.37 (15.86) |
-49.44% | Details | |
| 10/16/2018 | Spero Therapeutics | SPRO | Downgrade | Underperform (Neutral) |
9.60 (2.30) |
-76.04% | Details | |
| 10/4/2018 | Abbvie | ABBV | Maintain | Buy (N/A) |
|
Details | ||
| 8/27/2018 | Nabriva Therapeutics AG | NBRV | Maintain | Buy (Buy) |
|
Details | ||
| 8/27/2018 | Paratek Pharmaceuticals | PRTK | New Coverage | Neutral (N/A) |
10.35 (2.23) |
-78.45% | Details |
